# SH3BGRL proteins are thioredoxin fold–containing actin filament pointed end capping proteins (TPECs)

**Authors:** Robin S. Heiringhoff, Daniel Marke, Ute Curth, Johannes N. Greve

PMC · DOI: 10.1038/s41598-025-34096-y · Scientific Reports · 2026-01-21

## TL;DR

This paper reveals that SH3BGRL proteins help regulate actin filaments by capping their ends, using a thioredoxin fold in a non-enzymatic way.

## Contribution

The study identifies a new function for SH3BGRL proteins as non-enzymatic actin filament capping proteins with a thioredoxin fold.

## Key findings

- SH3BGRL proteins promote actin nucleation by stabilizing actin dimers and trimers.
- They inhibit actin subunit addition at the pointed end by directly associating with terminal subunits.
- SH3BGRL proteins can form a tripartite complex with actin and tropomodulin to enhance pointed end capping.

## Abstract

Cellular actin dynamics are tightly regulated by actin-binding proteins with specialized domains. Here, we identify SH3BGRL proteins as modulators of actin dynamics, characterized by their thioredoxin (Trx) fold and the absence of the canonical enzymatic site. The Trx fold is generally associated with enzymatic activity; however, in this context, it functions non-enzymatically to enhance actin nucleation, inhibit depolymerization and cap the growing pointed end of the actin filament. Our results indicate that all SH3BGRL isoforms weakly promote actin nucleation in vitro by stabilizing energetically unstable actin dimers and trimers. Using molecular dynamics simulations and assays that directly probe the pointed end of the actin filament, we show that SH3BGRL proteins efficiently inhibit actin subunit addition at the pointed end by direct association with the terminal actin subunits. However, SH3BGRL proteins are less effective at preventing subunit loss from the pointed end, but they can cooperate with tropomodulin to enhance this activity in an isoform-specific manner, indicating that all isoforms are capable of forming a tripartite complex with actin and tropomodulin. Based on our results, we propose a new and more appropriate name that reflects the function of the SH3BGRL protein family: thioredoxin fold–containing pointed end capping proteins (TPECs).

The online version contains supplementary material available at 10.1038/s41598-025-34096-y.

## Linked entities

- **Genes:** SH3BGRL (SH3 domain binding glutamate rich protein like) [NCBI Gene 6451]
- **Proteins:** ACTIN (hypothetical protein)

## Full-text entities

- **Genes:** GSN (gelsolin) [NCBI Gene 2934] {aka ADF, AGEL, AMYLD4}, Sh3bgrl (SH3-binding domain glutamic acid-rich protein like) [NCBI Gene 56726] {aka 1190008F14Rik}, ACT1 (actin) [NCBI Gene 850504] {aka ABY1, END7}, SH3BGR (SH3 domain binding glutamate rich protein) [NCBI Gene 6450] {aka 21-GARP}, CAT (catalase) [NCBI Gene 847], CP (ceruloplasmin) [NCBI Gene 1356] {aka AB073614, CP-2}, TMOD1 (tropomodulin 1) [NCBI Gene 7111] {aka D9S57E, ETMOD, TMOD}, Tmod3 (tropomodulin 3) [NCBI Gene 50875] {aka U-Tmod, UTMOD}, GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, TMOD3 (tropomodulin 3) [NCBI Gene 29766] {aka UTMOD}, PFN1 (profilin 1) [NCBI Gene 5216] {aka ALS18, PDB7}, CFL1 (cofilin 1) [NCBI Gene 1072] {aka CFL, HEL-S-15, cofilin}, TMSB4X (thymosin beta 4 X-linked) [NCBI Gene 7114] {aka FX, PTMB4, TB4X, TMSB4}, SH3BGRL (SH3 domain binding glutamate rich protein like) [NCBI Gene 6451] {aka HEL-S-115}, DIAPH1 (diaphanous related formin 1) [NCBI Gene 1729] {aka DFNA1, DIA1, DRF1, LFHL1, SCBMS, hDIA1}, Tmod1 (tropomodulin 1) [NCBI Gene 21916] {aka E-Tmod, Tmod}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, Sh3bgrl2 (SH3 domain binding glutamic acid-rich protein like 2) [NCBI Gene 212531] {aka A930014C21Rik, B930089I21}, Sh3bgrl3 (SH3 domain binding glutamic acid-rich protein-like 3) [NCBI Gene 73723] {aka 1110004L05Rik}, SH3BGRL3 (SH3 domain binding glutamate rich protein like 3) [NCBI Gene 83442] {aka HEL-S-297, SH3BP-1, TIP-B1}, ARL6IP5 (ARF like GTPase 6 interacting protein 5) [NCBI Gene 10550] {aka DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b}, TXN (thioredoxin) [NCBI Gene 7295] {aka TRDX, TRX, TRX1, TXN1, Trx80}, SH3BGRL2 (SH3 domain binding glutamate rich protein like 2) [NCBI Gene 83699]
- **Diseases:** colon cancer (MESH:D015179), breast carcinoma (MESH:D001943), carcinogenesis (MESH:D063646)
- **Chemicals:** DTT (MESH:D004229), chloride (MESH:D002712), HEPES (MESH:D006531), oil (MESH:D009821), hydrogen (MESH:D006859), NaCl (MESH:D012965), water (MESH:D014867), methylcellulose (MESH:D008747), KCl (MESH:D011189), Nucleotide (MESH:D009711), pepstatin (MESH:C031375), TCEP (MESH:C080938), EDTA (MESH:D004492), CaCl2 (MESH:D002122), EGTA (MESH:D004533), ATP (MESH:D000255), 2xTIRF (-), cysteine (MESH:D003545), sodium (MESH:D012964), MgCl2 (MESH:D015636), N-(1-pyrene)iodoacetamide (MESH:C029358), P (MESH:D010758), epsilon-ATP (MESH:D004985), GSH (MESH:D005978), imidazole (MESH:C029899), ATTO-655 (MESH:C585841), nitrogen (MESH:D009584), Pyrene (MESH:C030984), SDS (MESH:D012967), glucose (MESH:D005947), leupeptin (MESH:C032854), TPCK (MESH:D014108), LatB (MESH:C037068), amino acid (MESH:D000596), Sepharose (MESH:D012685)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Gallus gallus (bantam, species) [taxon 9031], Danio rerio (leopard danio, species) [taxon 7955]
- **Mutations:** E334Q, S368fs
- **Cell lines:** Rosetta2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), HCT116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), HKe-3 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_9796)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12827327/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12827327/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12827327/full.md

---
Source: https://tomesphere.com/paper/PMC12827327